Rare Cancers Australia and Australian Genomics invite you to a policy roundtable series exploring the enablers and barriers to genomic-led cancer care for people diagnosed with rare, less common and complex cancers. Your valuable perspective will contribute to discussions and a report, with practical recommendations for accelerating equitable access to genomic-led cancer care in Australia. Hear from experts in the field and share your own ideas, challenges and opportunities.

Two-year-old Luna’s family is fundraising for treatments only available overseas for her rare childhood cancer, neuroblastoma. They sat down with Gary Hardgrave on the 4BC Radio Drive program to share their experiences.

People living with cancer urgently need action on expanded access to precision therapies

Over the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.

With this expanded knowledge of cancer there are several promising treatments that can specifically target the drivers of an individual’s cancer, that are already under review through Australia’s health technology assessment process. Too many people living with cancer in Australia still don’t have access; and they can’t afford to wait.